<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   1186
  </number>
  <updateDate>
   2023-01-11T13:47:19Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:47:19Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-02-18
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 31 (Thursday, February 18, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. VAN DREW:H.R. 1186.Congress has the power to enact this legislation pursuantto the following:The Congress shall have power to lay and collect taxes,duties, imposts and excises, to pay the debts and provide forthe common defense and general welfare of the United States;but all duties, imposts and excises shall be uniformthroughout the United States.[Page H538]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-19T22:48:25Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-02-18T17:43:45Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-02-19
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-02-18
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-02-18
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-18
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     V000133
    </bioguideId>
    <fullName>
     Rep. Van Drew, Jefferson [R-NJ-2]
    </fullName>
    <firstName>
     Jefferson
    </firstName>
    <lastName>
     Van Drew
    </lastName>
    <party>
     R
    </party>
    <state>
     NJ
    </state>
    <district>
     2
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     B001307
    </bioguideId>
    <fullName>
     Rep. Baird, James R. [R-IN-4]
    </fullName>
    <firstName>
     James
    </firstName>
    <lastName>
     Baird
    </lastName>
    <party>
     R
    </party>
    <state>
     IN
    </state>
    <middleName>
     R.
    </middleName>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-02-18
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001190
    </bioguideId>
    <fullName>
     Rep. Mullin, Markwayne [R-OK-2]
    </fullName>
    <firstName>
     Markwayne
    </firstName>
    <lastName>
     Mullin
    </lastName>
    <party>
     R
    </party>
    <state>
     OK
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-10-25
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-02-18
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-04-01T21:14:10Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Supply Chain Security and Pharmaceutical Authentication Act of 2021 &lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill modifies the application of requirements for drug packaging to include certain information, such as the product's lot number and expiration date. &lt;/p&gt; &lt;p&gt;Under the bill, the requirements shall apply to the packaging of the smallest or individual solid oral dosage form of the product. Currently, such requirements apply to the smallest container (which might contain multiple dosages) of the product that is intended for individual sale to a dispenser, such as a pharmacy.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Supply Chain Security and Pharmaceutical Authentication Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Supply Chain Security and Pharmaceutical Authentication Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Supply Chain Security and Pharmaceutical Authentication Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-02-18T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr1186ih/xml/BILLS-117hr1186ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-19
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-02-19
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-18
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
2021-02-18T17:43:45Z
Referred to
House
Energy and Commerce Committee
2021-02-19T22:48:25Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
B001307
4
James
Rep. Baird, James R. [R-IN-4]
Baird
R.
R
2021-02-18
IN
M001190
2
Markwayne
Rep. Mullin, Markwayne [R-OK-2]
Mullin
R
2021-10-25
OK
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-02-18
2021-02-19
Referred to the Subcommittee on Health.
House
Health
V000133
2
Jefferson
Rep. Van Drew, Jefferson [R-NJ-2]
N
Van Drew
R
NJ
Drug safety, medical device, and laboratory regulation Manufacturing
2021-02-18
Introduced in House
 <p><b>Supply Chain Security and Pharmaceutical Authentication Act of 2021 </b></p> <p>This bill modifies the application of requirements for drug packaging to include certain information, such as the product's lot number and expiration date. </p> <p>Under the bill, the requirements shall apply to the packaging of the smallest or individual solid oral dosage form of the product. Currently, such requirements apply to the smallest container (which might contain multiple dosages) of the product that is intended for individual sale to a dispenser, such as a pharmacy.</p>
2021-04-01T21:14:10Z
00
2021-02-18T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr1186ih/xml/BILLS-117hr1186ih.xml
Supply Chain Security and Pharmaceutical Authentication Act of 2021
Supply Chain Security and Pharmaceutical Authentication Act of 2021
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Supply Chain Security and Pharmaceutical Authentication Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:47:19Z
2023-01-11T13:47:19Z
3.0.0
2021-02-19
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-18
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-18
9
Library of Congress
Introduced in House
IntroReferral
V000133
2
Jefferson
Rep. Van Drew, Jefferson [R-NJ-2]
N
Van Drew
R
NJ
B001307
4
James
Rep. Baird, James R. [R-IN-4]
Baird
R.
R
2021-02-18
IN
M001190
2
Markwayne
Rep. Mullin, Markwayne [R-OK-2]
Mullin
R
2021-10-25
OK
Drug safety, medical device, and laboratory regulation Manufacturing
2021-02-18
Introduced in House
 <p><b>Supply Chain Security and Pharmaceutical Authentication Act of 2021 </b></p> <p>This bill modifies the application of requirements for drug packaging to include certain information, such as the product's lot number and expiration date. </p> <p>Under the bill, the requirements shall apply to the packaging of the smallest or individual solid oral dosage form of the product. Currently, such requirements apply to the smallest container (which might contain multiple dosages) of the product that is intended for individual sale to a dispenser, such as a pharmacy.</p>
2021-04-01T21:14:10Z
00
Supply Chain Security and Pharmaceutical Authentication Act of 2021
Supply Chain Security and Pharmaceutical Authentication Act of 2021
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Supply Chain Security and Pharmaceutical Authentication Act of 2021
Short Title(s) as Introduced
2021-02-19
Referred to the Subcommittee on Health.